Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 2025 (Report No. 3)
Date of Filing: December 10, 2025
This filing serves to disseminate a press release regarding the presentation of clinical data at the Radiological Society of America (RSA) 2025 Annual Meeting. The Company focuses on cryoablation technology, specifically the ProSense® system.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a current report regarding a corporate event and does not contain financial statements or quantitative financial data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document. The material update is operational and clinical in nature:
- IceCure's ProSense® Cryoablation system was featured in four independent breast cancer studies.
- These studies were presented at the Radiological Society of America 2025 Annual Meeting.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release highlighting the clinical validation of the Company's technology through independent studies. This suggests a focus on clinical evidence generation to support market adoption.
Risks and Contingencies: The filing text does not explicitly detail new risks, contingencies, or unusual items. It notes that the press release is incorporated by reference into existing Registration Statements on Form F-3 and Form S-8.
Investor Verification Checklist
- Verify the specific findings and endpoints of the four independent breast cancer studies presented at the RSA 2025 Annual Meeting.
- Review the full text of the press release (Exhibit 99.1) for details on study design and patient outcomes.
- Assess the potential impact of these clinical presentations on future regulatory approvals or commercial partnerships.
- Check subsequent filings for any updates on the Company's financial position, as this report contains no financial data.